Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis

By                      

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1628-1632

Spandidos Publications

Access to resources Recommend Favorite

Comparison of the efficacy of transcatheter arterial chemoembolization and sorafenib for advanced hepatocellular carcinoma

By                          

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 381-386

Spandidos Publications

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET

By Negrier S.   Jäger E.   Porta C.   McDermott D.   Moore M.   Bellmunt J.   Anderson S.   Cihon F.   Lewis J.   Escudier B.   Bukowski R.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 899-906

Humana Press, Inc

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study

By            

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 935-939

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

By Lind Pehr   Naucler Gisela   Holm Agneta   Gubanski Michael   Svensson Christer  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 230-233

Informa Healthcare

Access to resources Recommend Favorite